Cytek Biosciences Market Sentiment

Market sentiment signals for Cytek Biosciences (CTKB): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Overweight

Short Interest▲ 5.1% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Overweight

5 analysts

Options Flow (P/C)

—

Avg Consensus PT

-10.2%

Highest Price Target

+30.8%

Piper Sandler

Lowest Price Target

-47.7%

Goldman Sachs

Short Interest

5.1%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
May 13, 2026	Stephens & Co.	Mason Carrico—	-17.2%	$6 → $5	Maintained	Overweight
May 12, 2026	Morgan Stanley	Tejas Savant—	-4.1%	$6 → $6	Maintained	Equal-Weight
Jan 8, 2026	TD Cowen	Brendan Smith—	-12.8%	$4 → $5	Maintained	Buy
Nov 11, 2025	Piper Sandler	David Westenberg—	+30.8%	$8 → $8	Maintained	Overweight
May 28, 2025	Morgan Stanley	Tejas Savant—	+22.1%	$9 → $7	Maintained	Equal-Weight
May 12, 2025	Goldman Sachs	Matthew Sykes—	-47.7%	$4 → $3	Maintained	Sell
Mar 19, 2025	Stephens & Co.	Mason Carrico—	+4.6%	$6 → $6	Maintained	Overweight
Mar 4, 2025	Piper Sandler	David Westenberg—	+39.5%	$9 → $8	Maintained	Overweight
Mar 3, 2025	Goldman Sachs	Matthew Sykes—	-21.5%	$5 → $5	Maintained	Sell
Feb 3, 2025	Goldman Sachs	Matthew Sykes—	-8.5%	$5 → $5	Maintained	Sell
Jan 31, 2025	Goldman Sachs	Matthew Sykes—	-21.5%	$7 → $5	Downgrade	Buy→Sell
Nov 11, 2024	Piper Sandler	David Westenberg—	+48.2%	$8 → $9	Maintained	Overweight
Aug 13, 2024	Piper Sandler	David Westenberg—	+39.5%	$9 → $8	Maintained	Overweight
Aug 7, 2024	Goldman Sachs	Matthew Sykes—	+22.1%	$8 → $7	Maintained	Buy
May 13, 2024	Piper Sandler	David Westenberg—	+48.2%	$10 → $9	Maintained	Overweight
May 10, 2024	Goldman Sachs	Matthew Sykes—	+39.5%	$9 → $8	Maintained	Buy
Mar 6, 2024	Piper Sandler	David Westenberg—	+74.4%	$11 → $10	Maintained	Overweight
Feb 29, 2024	Goldman Sachs	Matthew Sykes—	+74.4%	$9 → $10	Maintained	Buy
Dec 14, 2023	Stephens & Co.	Mason Carrico—	+56.9%	$9	Initiate	Overweight
Nov 9, 2023	Morgan Stanley	Tejas Savant—	+22.1%	$8 → $7	Maintained	Equal-Weight